Advanced in Mantle Cell Lymphoma (MCL)

Stephen P. Robinson

Brighton, ENG, GB 
Advanced in Mantle Cell Lymphoma (MCL)
Brighton, ENG, GB 
OverviewLocationsClinical Research

Overview

Stephen Robinson practices in Brighton, United Kingdom. Mr. Robinson is rated as an Advanced expert by MediFind in the treatment of Mantle Cell Lymphoma (MCL). His top areas of expertise are Non-Hodgkin Lymphoma, Secondary Adrenal Insufficiency, Mantle Cell Lymphoma (MCL), Bone Marrow Transplant, and Bone Graft.

His clinical research consists of co-authoring 82 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 7 articles in the study of Mantle Cell Lymphoma (MCL).

Gender
Male

Locations

Brighton, ENG, United Kingdom
Other Locations
Teddington, ENG TW110LW, United Kingdom
Bristol, ENG, United Kingdom
London, ENG, United Kingdom
Middlesex, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Timing of Primary Surgery for Cleft Palate
Timing of Primary Surgery for Cleft Palate
Enrollment Status: Completed
Publish Date: August 13, 2021
Intervention Type: Procedure
Study Phase: Not Applicable
Multicenter Randomized Phase II Study to Evaluate the Efficacy of Prophylactic Transfer of CD4 Lymphocytes After T-cell Depleted Reduced Intensity HLA-Identical Sibling Transplantation for Haematological Cancers
Multicenter Randomized Phase II Study to Evaluate the Efficacy of Prophylactic Transfer of CD4 Lymphocytes After T-cell Depleted Reduced Intensity HLA-Identical Sibling Transplantation for Haematological Cancers
Enrollment Status: Unknown
Publish Date: February 12, 2019
Intervention Type: Other
Study Drug: CD4 Donor Lymphocytes
Study Phase: Phase 2
WT1 TCR Gene Therapy for Leukaemia: A Phase I/II Safety and Toxicity Study
WT1 TCR Gene Therapy for Leukaemia: A Phase I/II Safety and Toxicity Study
Enrollment Status: Completed
Publish Date: October 02, 2018
Intervention Type: Genetic
Study Phase: Phase 1/Phase 2
View 2 Less Clinical Trials

82 Total Publications

Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy Consortium.
Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy Consortium.
Journal: Neuro-oncology
Published: August 30, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Robinson's expertise for a condition
ConditionClose
    View All 16 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile